Preparation and reversible aggregation of human cells encased in biocompatible polysaccharide shell
- Authors: Mukhamadeeva, RA1, Mavlyutova, II1, Bondar OV1
-
Affiliations:
- Kazan (Volga Region) Federal University, Kazan
- Issue: Vol 7, No 3 (2012)
- Pages: 121-124
- Section: Articles
- URL: https://genescells.ru/2313-1829/article/view/121634
- DOI: https://doi.org/10.23868/gc121634
- ID: 121634
Cite item
Open Access
Access granted
Subscription or Fee Access
Abstract
A deposition of cationic (chitosan) and anionic (alginic
acid) polysaccharides onto the surface of normal and cancer
human cells was studied with the use of dynamic light
scattering. A method for preparation of multilayer polymeric
shell by means of electrostatic adsorption of polysaccharides
onto cell plasma membrane has been proposed. According to
confocal microscopy, the polymeric shell evenly covers the cell
and is 1-5 μm in thickness. Under experimental conditions,
the modification with polysaccharides inhibits human skin
fibroblasts growth but does not exhibit cytotoxicity to
HeLa cells. We developed an approach to controllable and
reversible aggregation of modified cells by their cross-linking
in the presence of calcium ion. Resulting aggregates have
spherical shape and the size of 100-500 μm. Proposed
approaches and methods represent an alternative to cell
microencapsulation technique and are of interest for the
development of three-dimensional cell models and their
delivery in vivo.
acid) polysaccharides onto the surface of normal and cancer
human cells was studied with the use of dynamic light
scattering. A method for preparation of multilayer polymeric
shell by means of electrostatic adsorption of polysaccharides
onto cell plasma membrane has been proposed. According to
confocal microscopy, the polymeric shell evenly covers the cell
and is 1-5 μm in thickness. Under experimental conditions,
the modification with polysaccharides inhibits human skin
fibroblasts growth but does not exhibit cytotoxicity to
HeLa cells. We developed an approach to controllable and
reversible aggregation of modified cells by their cross-linking
in the presence of calcium ion. Resulting aggregates have
spherical shape and the size of 100-500 μm. Proposed
approaches and methods represent an alternative to cell
microencapsulation technique and are of interest for the
development of three-dimensional cell models and their
delivery in vivo.
About the authors
R A Mukhamadeeva,
Kazan (Volga Region) Federal University, KazanKazan (Volga Region) Federal University, Kazan
I I Mavlyutova,
Kazan (Volga Region) Federal University, KazanKazan (Volga Region) Federal University, Kazan
O V Bondar
Kazan (Volga Region) Federal University, KazanKazan (Volga Region) Federal University, Kazan
References
- Barry F.P., Murphy J.M. Mesenchymal stem cells: clinical applications and biological characterization. Int. J. Biochem. Cell. Biol. 2004; 36(ΙV): 568-84.
- Woodley D.T., Remington J., Huang Y. et al. Intravenously injected human fibroblasts home to skin wounds, deliver type VII collagen, and promote wound healing. Mol. Ther. 2007; 15(ΙΙΙ): 628-35.
- Koizumi N., Inatomi T., Suzuki T. et al. Cultivated corneal epithelial stem cell transplantation in ocular surface disorders. Ophthalmology 2001; 108: 1569-74.
- Weidner N., Blesch A., Grill R.J. et al. Nerve growth factor - hypersecreting Schwann cell grafts augment and guide spinal cord axonal growth and remyelinate central nervous system axons in a phenotypically appropriate manner that correlates with expression of
- L1. J. Comparative Neurology 1999; 413: 495-506.
- Silva G.V., Litovsky S., Assad J.A.R. et al. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 2005; 111: 150-6.
- Kondo M., Wagers A.J., Manz M.G. et al. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu. Rev. Immunol. 2003; 21: 759-806.
- Habib M., Shapira-Schweitzer K., Caspi O. et al. A combined cell therapy and in-situ tissue-engineering approach for myocardial repair. Biomaterials 2011; 32: 7514-23.
- Chan B.P., Hui T.Y., Yeung C.W. et al. Self-assembled collagenhuman mesenchymal stem cell microspheres for regenerative medicine. Biomaterials 2007; 28: 4652-66.
- Murua A., Portero A., Orive G. et al. Cell microencapsulation technology: towards clinical application. Control Release 2008; 132: 76-83.
- Veerabadran N.G., Goli P.L., Stewart-Clark S.S. et al. Nanoencapsulation of stem cells within polyelectrolyte multilayer shells. Macromol. Biosci. 2007; 7: 877-82.
- Borisenko G.G., Zaitseva M.A., Chuvilin A.N. et al. DNA modification of live cell surface. Nucleic. Acids. Res. 2009; 37(ΙV): e28.
- Baruch L., Machluf M. Alginate-chitosan complex coacervation for cell encapsulation: effect on mechanical properties and on longterm viability. Biopolymers 2006; 82(VΙ): 570-9.
- Бондарь О.В., Сайфуллина Д.В., Мавлютова И.И. и др. Мониторинг дзета-потенциала клеток человека при снижении их жизнеспособности и взаимодействии с полимерами. Acta Naturae. 2012; 4(Ι(XΙΙ)): 99-102.
- Сайфуллина Д.В., Шахмаева И.И., Бондарь О.В. и др. При- менение электроаналитических методов для характеристики кле- ток человека. Клеточная трансплантология и тканевая инженерия 2012; 7(Ι(ΙΙΙ)): 86-91.
Supplementary files
